Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Archive
  • Info for
    • Authors
    • Reviewers
  • About Us
    • About the Ochsner Journal
    • Editorial Board
  • More
    • Alerts
    • Feedback
  • Other Publications
    • Ochsner Journal Blog

User menu

  • My alerts
  • Log in

Search

  • Advanced search
Ochsner Journal
  • Other Publications
    • Ochsner Journal Blog
  • My alerts
  • Log in
Ochsner Journal

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Archive
  • Info for
    • Authors
    • Reviewers
  • About Us
    • About the Ochsner Journal
    • Editorial Board
  • More
    • Alerts
    • Feedback
Case ReportCASE REPORTS AND CLINICAL OBSERVATIONS
Open Access

Acrometastasis in Breast Carcinoma

Caroline Galliano, R. Taylor Bragg, Paresh Rangani and Mark Froom
Ochsner Journal June 2023, 23 (2) 164-166; DOI: https://doi.org/10.31486/toj.22.0105
Caroline Galliano
1Louisiana State University School of Medicine, New Orleans, LA
BS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
R. Taylor Bragg
2Department of Radiology, Louisiana State University Health Sciences Center–New Orleans, New Orleans, LA
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Paresh Rangani
2Department of Radiology, Louisiana State University Health Sciences Center–New Orleans, New Orleans, LA
DO
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mark Froom
2Department of Radiology, Louisiana State University Health Sciences Center–New Orleans, New Orleans, LA
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: mfroom@lsuhsc.edu
  • Article
  • Figures & Data
  • References
  • Info & Metrics
  • PDF
Loading

Abstract

Background: Metastasis to the bone in breast cancer patients is common, but metastasis specifically to the appendicular skeleton is rare. A limited number of cases in the literature describe metastatic breast cancer to the distal limbs, also known as acrometastasis. Acrometastasis in a patient with breast cancer should prompt evaluation for diffuse metastatic disease.

Case Report: We describe the case of a patient with recurrent triple-negative metastatic breast cancer who presented with thumb pain and swelling. Radiograph of the hand demonstrated focal soft tissue swelling over the first distal phalanx with erosive changes to the bone. Palliative radiation to the thumb resulted in symptom improvement. However, the patient succumbed to widespread metastatic disease. At autopsy, the thumb lesion was confirmed as metastatic breast adenocarcinoma.

Conclusion: Metastatic breast carcinoma to the distal appendicular skeleton, specifically to the first digit, is a rare presentation of bony metastasis and can be an indication of late, widespread disease.

Keywords:
  • Breast neoplasms
  • hand bones
  • neoplasm metastasis

INTRODUCTION

The most common site of metastasis in patients with breast cancer is bone, with up to 75% of patients with stage IV disease developing skeletal metastases and thus having a poor prognosis.1 However, metastasis to the distal appendicular skeleton—acrometastasis—is a rare phenomenon. These lesions, which are found distal to the elbow and knee, indicate a rare presentation of disseminated oncologic disease. Few cases of breast cancer metastasis to the thumb have been reported in the literature.2,3 We describe the case of a 70-year-old female who presented to our institution with an erosive breast cancer metastasis to the left first distal phalanx.

CASE REPORT

A 70-year-old African American female with a medical history of diabetes mellitus and recurrent triple-negative metastatic breast cancer presented to the oncology clinic with 2 weeks of left thumb pain. She had been diagnosed with breast adenocarcinoma 5 years prior with a screening mammogram, and a biopsy that confirmed metaplastic carcinoma of her right breast. She underwent a lumpectomy and received adjuvant chemotherapy with docetaxel (Taxotere) and cyclophosphamide (Cytoxan). The patient was lost to follow-up for more than a year before returning to the clinic with a new right breast mass consistent with recurrent disease. After mastectomy and radiation, the patient was again lost to follow-up for 2.5 years.

She subsequently returned to the clinic and presented with complaints of dyspnea on exertion and left thumb pain. Swelling and mild ulceration were noted on physical examination (Figure 1). Left hand radiograph revealed eccentric focal soft tissue swelling and erosive changes involving the first distal phalanx (Figure 2). Given the patient's history of recurrent breast carcinoma and suspicious lung nodules found on subsequent imaging, the phalanx lesion was highly suggestive of osseous metastasis.

Figure 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 1.

Gross images of the lesion demonstrate swelling and ulceration at the distal first phalanx.

Figure 2.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 2.

(A) Oblique and (B) zoomed-in lateral views of the hand and first phalanx demonstrate an eccentric lytic and erosive lesion at the distal first phalanx with surrounding soft tissue edema.

After re-establishing care 5 months prior to her presentation with thumb pain, the patient underwent a radionuclide bone scan that showed no sites of abnormal radiotracer uptake suggestive of metastatic bone disease. Following her presentation for thumb pain with radiographic evidence suspicious for metastatic disease, the patient underwent a more aggressive workup with computed tomography (CT) scans of the chest, abdomen, and pelvis, as well as a brain magnetic resonance imaging (MRI) scan. She was found to have metastasis to her lungs, mediastinum, and brain.

The patient underwent 2 rounds of palliative radiation to her left thumb over the course of 2 weeks and 1 round of radiation to her brain. She experienced symptomatic relief in her thumb, but she died approximately 3 months after palliative treatment and 5 years after her initial diagnosis. At autopsy, the patient's lesion to the first phalanx was confirmed to be metastatic breast adenocarcinoma.

DISCUSSION

Breast cancer is the most common cancer to affect women worldwide, and metastatic disease most commonly involves bone. A large cohort study found that 22% of breast cancer patients developed bone metastasis over a mean follow-up period of 8.4 years.4 The median survival for patients with breast cancer and bone metastases is 40 months for patients with triple-negative breast cancer compared to 65 months for patients with estrogen/progesterone-receptor-positive cancer.5

Radiographically, osseous metastasis from breast cancer can have several different appearances including osteolytic, osteoblastic, and mixed lesions, with approximately half of the lesions appearing osteolytic.6 Radionuclide bone scan is commonly used to detect bone metastases in patients with breast cancer, as the scan is widely available and cost effective. Radionuclide bone scan is the primary technique recommended for women with asymptomatic high-risk breast cancer and typically shows abnormal radiotracer accumulation in sites with increased osteoblastic activity and skeletal vascularity.7 Plain x-rays often depict variable findings of metastatic disease, including osteolytic lesions as disrupted or absent trabecular structure or foci of sclerosis.6 Detection with CT scan is a more sensitive test (71% to 100%) compared to plain radiographs,6 as CT can often detect metastasis in the marrow before bone destruction is apparent. MRI scans can also detect bone marrow metastasis, evidenced by reduced signal on T1, and often with better resolution than CT scans.6 Although our patient was lost to follow-up twice, her case demonstrates the paramount importance of radiographic surveillance for metastatic disease throughout the disease course and treatment.

Although osseous breast metastasis is common, metastasis to the distal appendicular skeleton is rare, with metastasis to the hand found in only 0.1% of cases.8 The first case of acrometastasis of the hand was reported in 1906.9 Since then, only a few other cases have been reported in the literature.2,3,8,10,11 Because hand lesions can present similarly to other disease processes with nonspecific symptoms such as pain, swelling, and ulcerations, differentials to this type of bone metastasis include infection, arthritis, gout, and epidermal inclusion cysts. Therefore, diagnosis aided by imaging is crucial because acrometastasis has a poor prognosis and can be associated with widespread disease. Metastatic disease to the distal extremities has been hypothesized to occur through hematogenous spread as opposed to lymphatic spread.10 When tumor emboli reach the distal extremities, clinicians should have a high suspicion of tumor deposits elsewhere in the body. Case management is focused on palliative care and thus on symptom control with local radiation, bisphosphonates, curettage, or amputation.12

CONCLUSION

Although bone is the most common site of metastasis in breast cancer, involvement of the distal limb and hand is a rare phenomenon. This finding can be an indication of more widespread disease, prompting additional evaluation for other sites of metastasis. Our case demonstrates a rare occurrence of metastatic breast carcinoma of the first digit and the importance of imaging in a thorough evaluation of this disease presentation.

This article meets the Accreditation Council for Graduate Medical Education and the American Board of Medical Specialties Maintenance of Certification competencies for Patient Care and Medical Knowledge.

ACKNOWLEDGMENTS

The authors have no financial or proprietary interest in the subject matter of this article.

  • ©2023 by the author(s); Creative Commons Attribution License (CC BY)

©2023 by the author(s); licensee Ochsner Journal, Ochsner Clinic Foundation, New Orleans, LA. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (creativecommons.org/licenses/by/4.0/legalcode) that permits unrestricted use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.

REFERENCES

  1. 1.↵
    1. Brook N,
    2. Brook E,
    3. Dharmarajan A,
    4. Dass CR,
    5. Chan A
    . Breast cancer bone metastases: pathogenesis and therapeutic targets. Int J Biochem Cell Biol. 2018;96:63-78. doi: 10.1016/j.biocel.2018.01.003
    OpenUrlCrossRef
  2. 2.↵
    1. Asthana S,
    2. Deo SV,
    3. Shukla NK,
    4. Raina V
    . Carcinoma breast metastatic to the hand and the foot. Australas Radiol. 2001;45(3):380-382. doi: 10.1046/j.1440-1673.2001.00943.x
    OpenUrlCrossRefPubMed
  3. 3.↵
    1. Bloom RA,
    2. Sulkes A,
    3. Freilick G,
    4. Libson E
    . Breast metastases to bones of the extremities: simultaneous involvement of all four limbs. Clin Oncol (R Coll Radiol). 1992;4(1):58-59. doi: 10.1016/s0936-6555(05)80780-0
    OpenUrlCrossRefPubMed
  4. 4.↵
    1. Harries M,
    2. Taylor A,
    3. Holmberg L,
    4. et al.
    Incidence of bone metastases and survival after a diagnosis of bone metastases in breast cancer patients. Cancer Epidemiol. 2014;38(4):427-434. doi: 10.1016/j.canep.2014.05.005
    OpenUrlCrossRefPubMed
  5. 5.↵
    1. Lee SJ,
    2. Park S,
    3. Ahn HK,
    4. et al.
    Implications of bone-only metastases in breast cancer: favorable preference with excellent outcomes of hormone receptor positive breast cancer. Cancer Res Treat. 2011;43(2):89-95. doi: 10.4143/crt.2011.43.2.89
    OpenUrlCrossRefPubMed
  6. 6.↵
    1. Hamaoka T,
    2. Madewell JE,
    3. Podoloff DA,
    4. Hortobagyi GN,
    5. Ueno NT
    . Bone imaging in metastatic breast cancer. J Clin Oncol. 2004;22(14):2942-2953. doi: 10.1200/JCO.2004.08.181
    OpenUrlAbstract/FREE Full Text
  7. 7.↵
    1. Pesapane F,
    2. Downey K,
    3. Rotili A,
    4. Cassano E,
    5. Koh DM
    . Imaging diagnosis of metastatic breast cancer. Insights Imaging. 2020;11(1):79. doi: 10.1186/s13244-020-00885-4
    OpenUrlCrossRef
  8. 8.↵
    1. Flynn CJ,
    2. Danjoux C,
    3. Wong J,
    4. et al.
    Two cases of acrometastasis to the hands and review of the literature. Curr Oncol. 2008;15(5):51-58. doi: 10.3747/co.v15i5.189
    OpenUrlCrossRefPubMed
  9. 9.↵
    1. Handley WS
    . Cancer of the Breast and its Operative Treatment. John Murray; 1906.
  10. 10.↵
    1. Stomeo D,
    2. Tulli A,
    3. Ziranu A,
    4. Perisano C,
    5. De Santis V,
    6. Maccauro G
    . Acrometastasis: a literature review. Eur Rev Med Pharmacol Sci. 2015;19(15):2906-2915.
    OpenUrlPubMed
  11. 11.↵
    1. Umana GE,
    2. Scalia G,
    3. Palmisciano P,
    4. et al.
    Acrometastases to the hand: a systematic review. Medicina (Kaunas). 2021;57(9):950. doi: 10.3390/medicina57090950
    OpenUrlCrossRef
  12. 12.↵
    1. Osterhouse MD,
    2. Guebert GM
    . Bilateral acrometastasis secondary to breast cancer. J Manipulative Physiol Ther. 2004;27(4):275-279. doi: 10.1016/j.jmpt.2004.02.007
    OpenUrlCrossRefPubMed
PreviousNext
Back to top

In this issue

Ochsner Journal: 23 (2)
Ochsner Journal
Vol. 23, Issue 2
Jun 2023
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
Print
Download PDF
Email Article

Thank you for your interest in spreading the word on Ochsner Journal.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Acrometastasis in Breast Carcinoma
(Your Name) has sent you a message from Ochsner Journal
(Your Name) thought you would like to see the Ochsner Journal web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Acrometastasis in Breast Carcinoma
Caroline Galliano, R. Taylor Bragg, Paresh Rangani, Mark Froom
Ochsner Journal Jun 2023, 23 (2) 164-166; DOI: 10.31486/toj.22.0105

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Acrometastasis in Breast Carcinoma
Caroline Galliano, R. Taylor Bragg, Paresh Rangani, Mark Froom
Ochsner Journal Jun 2023, 23 (2) 164-166; DOI: 10.31486/toj.22.0105
del.icio.us logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • INTRODUCTION
    • CASE REPORT
    • DISCUSSION
    • CONCLUSION
    • ACKNOWLEDGMENTS
    • REFERENCES
  • Figures & Data
  • References
  • Info & Metrics
  • PDF

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Management of Spontaneous Renal Arteriovenous Fistula in Pregnancy
  • Cerebellar Ataxia With Neuropathy and Bilateral Vestibular Areflexia Syndrome Coexisting With JAK2-Positive Polycythemia Vera and Myelofibrosis
  • Excessive Ingestion of Almond Milk Causes Severe Hypercalcemia and Acute Kidney Injury in a Patient With Chronic Kidney Disease
Show more CASE REPORTS AND CLINICAL OBSERVATIONS

Similar Articles

Keywords

  • Breast neoplasms
  • hand bones
  • neoplasm metastasis

Ochsner Journal Blog

Current Post

Be Careful Where You Publish

Our Content

  • Home
  • Current Issue
  • Ahead of Print
  • Archive
  • Featured Contributors
  • Ochsner Journal Blog
  • Archive at PubMed Central

Information & Forms

  • Instructions for Authors
  • Instructions for Reviewers
  • Submission Checklist
  • FAQ
  • License for Publishing-Author Attestation
  • Patient Consent Form
  • Submit a Manuscript

Services & Contacts

  • Permissions
  • Sign up for our electronic table of contents
  • Feedback Form
  • Contact Us

About Us

  • Editorial Board
  • About the Ochsner Journal
  • Ochsner Health
  • University of Queensland-Ochsner Clinical School
  • Alliance of Independent Academic Medical Centers

© 2025 Ochsner Clinic Foundation

Powered by HighWire